SCHEMBL18546

SCHEMBL18546

CC(C)N(C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(O)cc1)C(C)C

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 16/20 0.61
JAK2 O60674 1/20 0.56
MAPT P10636 1/20 0.56
GCK P35557 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409 0.89 GCKR (0.58) GCKRJAK2MAPTGCK
SCHEMBL18703 0.88 GCKR (0.57) GCKRJAK2MAPTGCK
SCHEMBL12089761 0.88 GCKR (0.64) GCKRGCK
SCHEMBL19792 0.88 GCKR (0.59) GCKRJAK2MAPTGCK
SCHEMBL17387 0.88 GCKR (0.62) GCKRJAK2MAPTGCK
SCHEMBL17328 0.88 GCKR (0.62) GCKRJAK2MAPTGCK
SCHEMBL19242 0.88 GCKR (0.56) GCKRJAK2MAPTGCK
SCHEMBL18818 0.87 GCKR (0.56) GCKRJAK2MAPTGCK
SCHEMBL17227 0.86 GCKR (0.66) GCKRJAK2MAPTGCK
SCHEMBL17231 0.86 GCKR (0.66) GCKRJAK2MAPTGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431563-B2 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes AMGEN INC. (US) 2013-04-30 US disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed